We designed an in vitro system for generating and testing EVs carrying autoantigen-loaded HLA class I molecules using the T1D risk–associated HLA-A*02 (HLA-A2), plus costimulation with or without PD-L1 coinhibition. This evidence concerns the gene HLA-A and type 1 diabetes mellitus.